Cisen Pharmaceutical Co., Ltd.

603367

CNE100002VG4

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
15.84 ^CNY	-0.25%		+3.94%	+8.20%

Apr. 23	Cisen Pharmaceutical Names Chief Financial Officer	MT
Apr. 22	Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Cisen Pharmaceutical Co., Ltd.(XSSC:603367) dropped from S&P Global BMI Index

December 20, 2021 at 12:00 am EST

Latest news about Cisen Pharmaceutical Co., Ltd.

Cisen Pharmaceutical Names Chief Financial Officer	Apr. 23	MT
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 22	CI
Cisen Pharmaceutical Scraps Unit Spin-Off Plan	Dec. 01	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Cisen Pharmaceutical Co., Ltd.(XSSC:603367) added to S&P Global BMI Index	23-09-18	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Cisen Pharmaceutical to Spin Off Unit for Shenzhen Float	23-06-09	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Cisen Pharmaceutical Secures Regulatory Approval for Methylcobalamin Tablets	22-11-22	MT
Cisen Pharmaceutical Gets Regulatory Approval for Registration of Two Drugs	22-11-17	MT
Cisen Pharma Gets Regulatory Nod For Flu Drug's China Clinical Trial	22-11-09	MT
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-17	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI
Shijiazhuang No.4 Pharmaceutical Co., Ltd. completed the acquisition of 6.1% stake in Cisen Pharmaceutical Co., Ltd. from Wu Hengke.	21-12-30	CI
Cisen Pharmaceutical Co., Ltd.(XSSC:603367) dropped from S&P Global BMI Index	21-12-20	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Sichuan Kelun Pharmaceutical Co., Ltd. completed the acquisition of 10% stake in Cisen Pharmaceutical Co., Ltd. from Tianjin Qianding Enterprise Management Partnership (Limited Partnership).	21-09-13	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-18	CI
Shijiazhuang No.4 Pharmaceutical Co., Ltd. entered into an agreement to acquire 6.1% stake in Cisen Pharmaceutical Co., Ltd. from Wu Hengke for approximately CNY 350 million.	21-07-28	CI
Sichuan Kelun Pharmaceutical Co., Ltd. agreed to acquire 10% stake in Cisen Pharmaceutical Co., Ltd. from Tianjin Qianding Enterprise Management Partnership (Limited Partnership) for approximately CNY 580 million.	21-07-27	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-08	CI

Chart Cisen Pharmaceutical Co., Ltd.

Duration

Period

More charts

Cisen Pharmaceutical Co., Ltd is a China-based company principally involved in the research, development, manufacturing and sales of medical products. The Company operates through two main segments. The Main Business segment is primarily involved in the manufacturing and sales of medicine, among which include infusion, freeze-dried powder, small volume injection, tablet, capsules, ointment, drops and active pharmaceutical ingredients, among others. The Other Business segment is mainly involved in the sales of raw materials and houses tenancy.

Sector

Pharmaceuticals

Calendar

2024-05-21 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
CISEN PHARMACEUTICAL CO., LTD.	+8.20%	992M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.81%	43.34B
OTSUKA HOLDINGS CO., LTD.	+22.75%	21.96B
SANDOZ GROUP AG	+13.30%	14.09B
CIPLA LIMITED	+12.97%	13.64B
ZYDUS LIFESCIENCES LIMITED	+39.74%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-10.75%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+9.64%	5.22B